Anika Therapeutics

Anika Therapeutics, Inc. is a global company focused on joint preservation and the development of innovative therapies for orthopedic care. The company specializes in addressing degenerative orthopedic diseases and traumatic conditions through clinically meaningful treatments. Its product portfolio includes solutions for osteoarthritis pain management, regenerative therapies, soft tissue repair, and technologies aimed at preserving bone and joint integrity. Anika Therapeutics collaborates with healthcare providers to understand their needs and create minimally invasive products that enhance patient outcomes and promote active living. The majority of the company's revenue is generated from the United States, reflecting its commitment to improving the quality of life for patients worldwide.

Steve Griffin

CFO

3 past transactions

Parcus Medical

Acquisition in 2020
Parcus Medical, LLC is a manufacturer that specializes in designing, producing, and distributing surgical products for orthopedic surgeons. Founded in 2007, the company is based in Sturgeon Bay, Wisconsin, and operates as a subsidiary of Anika Therapeutics, Inc. Parcus Medical offers a wide range of products, including suture anchors, interference screws, tenodesis systems, graft fixation systems, and various surgical instrumentation. These products are specifically utilized in sports medicine procedures aimed at repairing injuries to the shoulder, knee, hip, and distal extremities. By providing innovative solutions, Parcus Medical supports orthopedic surgeons in restoring patient function and mobility.

Arthrosurface

Acquisition in 2020
Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures implant systems for various joints, including the knee, shoulder, wrist, hip, foot and ankle, and toe, aimed at treating conditions related to trauma, injury, and arthritis. Its products are engineered to preserve native joint anatomy and biomechanics, allowing for improved range of motion and reduced pain. Arthrosurface's innovations, such as the HemiCAP system, enable patients to undergo procedures with shorter hospital stays and quicker recoveries, facilitating a return to active lifestyles. The company markets its devices through a network of sales representatives and distributors both in the United States and internationally. Since February 2020, Arthrosurface has operated as a subsidiary of Anika Therapeutics, Inc.

Fidia Farmaceutici

Acquisition in 2009
Fidia Farmaceutici is an Italian multinational company based in Abano Terme, specializing in the research, development, manufacturing, marketing, and sales of healthcare and pharmaceutical products. The company has a diverse product portfolio primarily focused on hyaluronic acid (HA), which is utilized in various fields including joint care, wound healing, ophthalmology, aesthetics, and autologous biological therapy. Fidia offers a wide range of sterile, lyophilized, and injectable products, as well as ointments, creams, gels, solid oral forms, and eye drops, catering to the pharmaceutical and biomedical sectors with innovative treatments for common medical conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.